Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

7YG3

Crystal structure of HLA-B*13:01

Summary for 7YG3
Entry DOI10.2210/pdb7yg3/pdb
DescriptorMHC class I antigen, Beta-2-microglobulin, ARG-GLN-ASP-ILE-LEU-ASP-LEU-TRP-ILE, ... (4 entities in total)
Functional Keywordshla-b*13:01, t cell receptor, drug-induced hypersensitivity syndrome, immune system
Biological sourceHomo sapiens (human)
More
Total number of polymer chains3
Total formula weight44886.88
Authors
Wang, H.S.,Ouyang, S.Y. (deposition date: 2022-07-11, release date: 2023-07-26, Last modification date: 2024-10-09)
Primary citationJiang, H.,Wang, C.W.,Wang, Z.,Dai, Y.,Zhu, Y.,Lee, Y.S.,Cao, Y.,Chung, W.H.,Ouyang, S.,Wang, H.
Functional and structural characteristics of HLA-B*13:01-mediated specific T cells reaction in dapsone-induced drug hypersensitivity.
J.Biomed.Sci., 29:58-58, 2022
Cited by
PubMed Abstract: Severe cutaneous adverse drug reactions (SCARs) are a group of serious clinical conditions caused by immune reaction to certain drugs. The allelic variance of human leukocyte antigens of HLA-B*13:01 has been strongly associated with hypersensitivities induced by dapsone (DDS). T-cell receptor mediated activation of cytotoxic T lymphocytes (CTLs) has also been suggested to play an essential role in pathogenesis of SCARs. However, HLA-B*13:01-DDS-TCR immune synapse that plays role in drug-induced hypersensitivity syndrome (DIHS) associated T cells activation remains uncharacterized.
PubMed: 35964029
DOI: 10.1186/s12929-022-00845-8
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.5 Å)
Structure validation

237423

PDB entries from 2025-06-11

PDB statisticsPDBj update infoContact PDBjnumon